GoHealth, Inc. is a holding company and the sole managing member of GoHealth Holdings, LLC, and its principal asset consists of LLC Interests.
Company profile
Ticker
GOCO
Exchange
Website
CEO
Clinton P. Jones
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
GoHealth Holdings, LLC • Blizzard Midco, LLC • Norvax, LLC • GoHealth, LLC • Connected Benefits, LLC • GoHealth, s.r.o. ...
GOCO stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
20 Mar 24
10-K
2023 FY
Annual report
14 Mar 24
8-K/A
Results of Operations and Financial Condition
14 Mar 24
8-K
Results of Operations and Financial Condition
14 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Results of Operations and Financial Condition
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Results of Operations and Financial Condition
10 Aug 23
8-K
Departure of Directors or Certain Officers
6 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
25 May 23
Transcripts
GOCO
Earnings call transcript
2023 Q4
14 Mar 24
GOCO
Earnings call transcript
2023 Q3
9 Nov 23
GOCO
Earnings call transcript
2023 Q2
10 Aug 23
GOCO
Earnings call transcript
2023 Q1
8 May 23
GOCO
Earnings call transcript
2022 Q4
16 Mar 23
GOCO
Earnings call transcript
2022 Q3
11 Nov 22
GOCO
Earnings call transcript
2022 Q2
16 Aug 22
GOCO
Earnings call transcript
2022 Q1
11 May 22
GOCO
Earnings call transcript
2021 Q4
16 Mar 22
GOCO
Earnings call transcript
2021 Q3
10 Nov 21
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 26.39 mm | 26.39 mm | 26.39 mm | 26.39 mm | 26.39 mm | 26.39 mm |
Cash burn (monthly) | (no burn) | 15.75 mm | 18.77 mm | 24.97 mm | (no burn) | 263.25 k |
Cash used (since last report) | n/a | 104.47 mm | 124.49 mm | 165.61 mm | n/a | 1.75 mm |
Cash remaining | n/a | -78.08 mm | -98.11 mm | -139.22 mm | n/a | 24.64 mm |
Runway (months of cash) | n/a | -5.0 | -5.2 | -5.6 | n/a | 93.6 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 53 |
Opened positions | 21 |
Closed positions | 6 |
Increased positions | 8 |
Reduced positions | 9 |
13F shares | Current |
---|---|
Total value | 109.33 bn |
Total shares | 118.71 mm |
Total puts | 246.00 |
Total calls | 21.24 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
Norwest Equity Partners IX | 54.98 mm | $208.39 mm |
ELV Elevance Health | 32.91 mm | $11.59 mm |
Centerbridge Associates III | 9.57 mm | $166.83 mm |
CCP III Cayman GP | 9.46 mm | $132.63 mm |
NVX | 6.23 mm | $108.69 mm |
Centerbridge Partners | 4.18 mm | $82.38 bn |
BLK Blackrock | 258.85 k | $5.10 bn |
CI Private Wealth | 202.97 k | $4.00 bn |
Vanguard | 197.50 k | $3.89 bn |
Eversept Partners | 104.82 k | $2.07 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Apr 24 | Vijay Kotte | Class A Common Stock | Payment of exercise | Dispose F | No | No | 9.6 | 16,278 | 156.27 k | 805,304 |
10 Apr 24 | Jason Schulz | Class A Common Stock | Payment of exercise | Dispose F | No | No | 9.6 | 3,145 | 30.19 k | 305,702 |
1 Apr 24 | Brad Burd | Class A Common Stock | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 64,681 |
1 Apr 24 | Mike Hargis | Class A Common Stock | Grant | Acquire A | No | No | 0 | 100,000 | 0.00 | 260,231 |
1 Apr 24 | Vijay Kotte | Class A Common Stock | Grant | Acquire A | No | No | 0 | 166,666 | 0.00 | 821,582 |
1 Apr 24 | Vijay Kotte | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 10.65 | 83,333 | 887.50 k | 83,333 |
News
HHS Says In 2025, All People With Medicare Part D Will Benefit From A $2,000 Cap On Annual Out-Of-Pocket Prescription Drug Costs
26 Mar 24
RBC Capital Maintains Sector Perform on GoHealth, Lowers Price Target to $13
20 Mar 24
GoHealth Q4 GAAP EPS $(0.22) May Not Be Comparable To $2.73 Estimate, Sales $276.70M Miss $363.88M Estimate
14 Mar 24
Earnings Scheduled For March 14, 2024
14 Mar 24
Earnings Outlook For GoHealth
13 Mar 24